India: LeapFrog Investments leads $55m Series D funding in MedGenome

US and India-based Genetic diagnostics firm MedGenome Wednesday said it has raised $55 million in a fresh funding round led by global impact investment firm LeapFrog Investments.

Existing investors, Belgium-based Sofina and Sequoia Capital, also participated in the Series D round, MedGenome said in a statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter